Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.

In all non-tumor tissues, residual Pt (μg/g dried tissues) was lower in Tf-cisplatin treatment group compared to free cisplatin group, especially in liver and spleen where the difference had reached highly significant levels ( P < 0.01).

also in 132,142 other papers